Pharmena S.A. (WSE:PHR)
3.270
+0.020 (0.62%)
Apr 8, 2026, 2:47 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 36.2 million as of April 8, 2026. Its market cap has decreased by -29.19% in one year.
Market Cap
36.20M
Enterprise Value
28.83M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.27
Market Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 36.20M, a decrease of -78.95%. That is a compound annual growth rate of -8.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 36.20M | 25.00% |
| Dec 30, 2025 | 28.96M | -32.11% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 529.45M |
| Captor Therapeutics Spolka Akcyjna | 446.72M |
| Bioceltix | 406.76M |
| BIOTON | 369.22M |
| Synthaverse | 260.44M |
| Mabion | 138.67M |
| Molecure | 108.78M |
| NanoGroup | 81.91M |